Company news
Nutriband Inc. news in 2024
Nutriband Inc.'s news releases, calls and decks from 2024, newest first.
Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology
December 26, 2024
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025
December 3, 2024
Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology
November 26, 2024
Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica
October 16, 2024
Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology
September 23, 2024
Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch
September 19, 2024
Nutriband Inc. Authorizes $1M Share Buyback Program
September 15, 2024
Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology
July 14, 2024
Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl
June 19, 2024
Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors
May 15, 2024
Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission
April 23, 2024
Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group
April 22, 2024
Nutriband Inc. Announces $8.4M Private Placement
April 18, 2024
Nutriband Inc. Begins Manufacturing for Major Sports Brand Licensee Fit for Life Group, Whose Collection of Partnered Brands Include Reebok, Adidas and New Balance
March 31, 2024
Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal Patch
March 26, 2024
Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting
March 24, 2024
Nutriband Signs Commercial Development and Clinical Supply Agreement With Kindeva Drug Delivery for Aversa(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch
January 4, 2024